Long-term finasteride doesn't impair quality of life

Long-term finasteride doesn't impair quality of life
Taking finasteride to prevent prostate cancer does not negatively affect the physical function, mental health, or vitality domains of health-related quality of life, according to a study published online Sept. 12 in the Journal of the National Cancer Institute.

(HealthDay)—Taking finasteride to prevent prostate cancer does not negatively affect the physical function, mental health, or vitality domains of health-related quality of life, according to a study published online Sept. 12 in the Journal of the National Cancer Institute.

Carol M. Moinpour, Ph.D., from the Fred Hutchinson Cancer Research Center in Seattle, and colleagues examined the effect of finasteride on quality of life using data from questionnaires completed by Trial participants, who were randomized to finasteride or placebo for prevention of prostate cancer. Questionnaires were completed at enrollment (three months before randomization), six months after randomization, and annually for seven years. Three health-related quality-of-life domains were measured using the Health Survey Short Form 36: Physical Functioning, Mental Health, and Vitality scales.

The researchers found that finasteride had minor effects on physical function, accounting for less than a one-point difference over time in physical functioning scores. There were significant negative effects on physical function for comorbidities (including , leg pain, and diabetes), current smoking, and time on study. There were no significant effects of finasteride on mental health and vitality at any of the three time points, either in the mixed-effects analyses or in the cross-sectional analysis.

"In conclusion, taking finasteride for seven years did not appear to harm general aspects of health-related quality of life," the authors write.

Merck Inc. provided the drug and placebo used in the study.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Hair loss drug shows long-term sexual side effects

Jul 23, 2012

(HealthDay) -- For men with finasteride-associated side effects, sexual dysfunction may persist for months or years, even after discontinuation of the drug, according to a study published online July 12 in ...

Generic prostate drug helps find high-risk cancers early

Sep 11, 2007

Men now have another good reason to consider taking finasteride, a well-known generic drug that shrinks an enlarged prostate and reduces the risk of getting prostate cancer by 25 percent. A new study from the Southwest Oncology ...

Recommended for you

The fine line between breast cancer and normal tissues

6 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

7 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

10 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

12 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

User comments